153 related articles for article (PubMed ID: 33019945)
41. Combined modality treatment for locally advanced breast cancer.
Diaconu C; Gavrilovici V; Ghenghe D; Dragomir C; Cozma L; Ciornea L; Carasevici E
Acta Chir Belg; 2003; 103(6):589-92. PubMed ID: 14743564
[TBL] [Abstract][Full Text] [Related]
42. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
[TBL] [Abstract][Full Text] [Related]
43. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet Oncol; 2018 Jan; 19(1):27-39. PubMed ID: 29242041
[TBL] [Abstract][Full Text] [Related]
44. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
[TBL] [Abstract][Full Text] [Related]
45. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
46. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.
van der Hage JA; Putter H; Bonnema J; Bartelink H; Therasse P; van de Velde CJ;
Eur J Cancer; 2003 Oct; 39(15):2192-9. PubMed ID: 14522378
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
[TBL] [Abstract][Full Text] [Related]
48. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
49. Low rate of function-limiting side effects with high-dose adjuvant radiotherapy in high-grade soft tissue extremity sarcomas: a retrospective single-center analysis over 10 years.
Koeksal M; van der Hoek M; Scafa D; Koch D; Leitzen C; Schmeel LC; Feldmann G; Strauss A; Koob S; Giordano FA
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4877-4888. PubMed ID: 36287264
[TBL] [Abstract][Full Text] [Related]
50. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
Monrigal E; Dauplat J; Gimbergues P; Le Bouedec G; Peyronie M; Achard JL; Chollet P; Mouret-Reynier MA; Nabholtz JM; Pomel C
Eur J Surg Oncol; 2011 Oct; 37(10):864-70. PubMed ID: 21843920
[TBL] [Abstract][Full Text] [Related]
51. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
52. Soft tissue sarcomas after radiation treatment for breast cancer. Three case studies and review of literature.
Schulz U; Gokel JM; Poleska W
Strahlenther Onkol; 2000 Mar; 176(3):144-9. PubMed ID: 10742836
[TBL] [Abstract][Full Text] [Related]
53. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.
Barth RJ; Wells WA; Mitchell SE; Cole BF
Ann Surg Oncol; 2009 Aug; 16(8):2288-94. PubMed ID: 19424757
[TBL] [Abstract][Full Text] [Related]
54. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
55. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
56. Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
Huang L; Chen S; Yang WT; Shao Z
Oncotarget; 2017 Jun; 8(24):39703-39710. PubMed ID: 28055977
[TBL] [Abstract][Full Text] [Related]
57. Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
Kim K; Chie EK; Han W; Noh DY; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Tumori; 2011; 97(3):280-5. PubMed ID: 21789003
[TBL] [Abstract][Full Text] [Related]
58. Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.
Arsenault D; Hurley J; Takita C; Reis IM; Zhao W; Rodgers S; Wright JL
Am J Clin Oncol; 2015 Aug; 38(4):348-52. PubMed ID: 23799288
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
60. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.
Liljegren G; Holmberg L; Adami HO; Westman G; Graffman S; Bergh J
J Natl Cancer Inst; 1994 May; 86(9):717-22. PubMed ID: 8158702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
